JP2015089931A - Medical vinyl chloride resin composition and medical instrument composed of the same - Google Patents
Medical vinyl chloride resin composition and medical instrument composed of the same Download PDFInfo
- Publication number
- JP2015089931A JP2015089931A JP2013231033A JP2013231033A JP2015089931A JP 2015089931 A JP2015089931 A JP 2015089931A JP 2013231033 A JP2013231033 A JP 2013231033A JP 2013231033 A JP2013231033 A JP 2013231033A JP 2015089931 A JP2015089931 A JP 2015089931A
- Authority
- JP
- Japan
- Prior art keywords
- medical
- vinyl chloride
- chloride resin
- resin composition
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 title claims abstract description 83
- 239000011342 resin composition Substances 0.000 title claims abstract description 50
- 239000004014 plasticizer Substances 0.000 claims abstract description 32
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011347 resin Substances 0.000 claims abstract description 14
- 229920005989 resin Polymers 0.000 claims abstract description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 9
- 239000008158 vegetable oil Substances 0.000 claims abstract description 9
- HORIEOQXBKUKGQ-UHFFFAOYSA-N bis(7-methyloctyl) cyclohexane-1,2-dicarboxylate Chemical compound CC(C)CCCCCCOC(=O)C1CCCCC1C(=O)OCCCCCCC(C)C HORIEOQXBKUKGQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 10
- 238000001802 infusion Methods 0.000 claims description 9
- 150000004756 silanes Chemical class 0.000 claims description 4
- 238000007922 dissolution test Methods 0.000 abstract description 7
- 239000012567 medical material Substances 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 18
- -1 silane compound Chemical class 0.000 description 18
- 229920001577 copolymer Polymers 0.000 description 15
- 239000012085 test solution Substances 0.000 description 14
- 239000003381 stabilizer Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- CABDEMAGSHRORS-UHFFFAOYSA-N oxirane;hydrate Chemical compound O.C1CO1 CABDEMAGSHRORS-UHFFFAOYSA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 238000004898 kneading Methods 0.000 description 5
- 229910000077 silane Inorganic materials 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 239000012286 potassium permanganate Substances 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 235000012424 soybean oil Nutrition 0.000 description 4
- 239000003549 soybean oil Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- IHBCFWWEZXPPLG-UHFFFAOYSA-N [Ca].[Zn] Chemical compound [Ca].[Zn] IHBCFWWEZXPPLG-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 235000021388 linseed oil Nutrition 0.000 description 3
- 239000000944 linseed oil Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- URDOJQUSEUXVRP-UHFFFAOYSA-N 3-triethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)C(C)=C URDOJQUSEUXVRP-UHFFFAOYSA-N 0.000 description 2
- 239000005046 Chlorosilane Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- HGQSXVKHVMGQRG-UHFFFAOYSA-N dioctyltin Chemical compound CCCCCCCC[Sn]CCCCCCCC HGQSXVKHVMGQRG-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920001897 terpolymer Polymers 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- KKYDYRWEUFJLER-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,10,10,10-heptadecafluorodecyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCC(F)(F)F KKYDYRWEUFJLER-UHFFFAOYSA-N 0.000 description 1
- BEEPXSBZGLKIOT-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1=CC(F)=CC=C1N1C2(CCNCC2)C(=O)NC1 BEEPXSBZGLKIOT-UHFFFAOYSA-N 0.000 description 1
- AKLIBHVBNWYIGN-UHFFFAOYSA-N 1-ethyl-2-hexylcyclohexane-1,2-dicarboxylic acid Chemical compound C(C)C1(C(CCCC1)(C(=O)O)CCCCCC)C(=O)O AKLIBHVBNWYIGN-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OXYZDRAJMHGSMW-UHFFFAOYSA-N 3-chloropropyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)CCCCl OXYZDRAJMHGSMW-UHFFFAOYSA-N 0.000 description 1
- LVNLBBGBASVLLI-UHFFFAOYSA-N 3-triethoxysilylpropylurea Chemical compound CCO[Si](OCC)(OCC)CCCNC(N)=O LVNLBBGBASVLLI-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000004805 Cyclohexane-1,2-dicarboxylic acid Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Natural products CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- NOZAQBYNLKNDRT-UHFFFAOYSA-N [diacetyloxy(ethenyl)silyl] acetate Chemical compound CC(=O)O[Si](OC(C)=O)(OC(C)=O)C=C NOZAQBYNLKNDRT-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- SHLNMHIRQGRGOL-UHFFFAOYSA-N barium zinc Chemical compound [Zn].[Ba] SHLNMHIRQGRGOL-UHFFFAOYSA-N 0.000 description 1
- WZEFLOBFCQPVHR-UHFFFAOYSA-N bis(8-methylnonyl) cyclohexane-1,2-dicarboxylate Chemical compound CC(C)CCCCCCCOC(=O)C1CCCCC1C(=O)OCCCCCCCC(C)C WZEFLOBFCQPVHR-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- ANSWCYTXKAIJOK-UHFFFAOYSA-N dibutyl cyclohexane-1,2-dicarboxylate Chemical compound CCCCOC(=O)C1CCCCC1C(=O)OCCCC ANSWCYTXKAIJOK-UHFFFAOYSA-N 0.000 description 1
- UCJHMXXKIKBHQP-UHFFFAOYSA-N dichloro-(3-chloropropyl)-methylsilane Chemical compound C[Si](Cl)(Cl)CCCCl UCJHMXXKIKBHQP-UHFFFAOYSA-N 0.000 description 1
- ZTUZDYWYNQDJKR-UHFFFAOYSA-N diethyl cyclohexane-1,2-dicarboxylate Chemical compound CCOC(=O)C1CCCCC1C(=O)OCC ZTUZDYWYNQDJKR-UHFFFAOYSA-N 0.000 description 1
- VSYLGGHSEIWGJV-UHFFFAOYSA-N diethyl(dimethoxy)silane Chemical compound CC[Si](CC)(OC)OC VSYLGGHSEIWGJV-UHFFFAOYSA-N 0.000 description 1
- JJQZDUKDJDQPMQ-UHFFFAOYSA-N dimethoxy(dimethyl)silane Chemical compound CO[Si](C)(C)OC JJQZDUKDJDQPMQ-UHFFFAOYSA-N 0.000 description 1
- AHUXYBVKTIBBJW-UHFFFAOYSA-N dimethoxy(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](OC)(OC)C1=CC=CC=C1 AHUXYBVKTIBBJW-UHFFFAOYSA-N 0.000 description 1
- WHGNXNCOTZPEEK-UHFFFAOYSA-N dimethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](C)(OC)CCCOCC1CO1 WHGNXNCOTZPEEK-UHFFFAOYSA-N 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- YYLGKUPAFFKGRQ-UHFFFAOYSA-N dimethyldiethoxysilane Chemical compound CCO[Si](C)(C)OCC YYLGKUPAFFKGRQ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- WOXXJEVNDJOOLV-UHFFFAOYSA-N ethenyl-tris(2-methoxyethoxy)silane Chemical compound COCCO[Si](OCCOC)(OCCOC)C=C WOXXJEVNDJOOLV-UHFFFAOYSA-N 0.000 description 1
- DFJDZTPFNSXNAX-UHFFFAOYSA-N ethoxy(triethyl)silane Chemical compound CCO[Si](CC)(CC)CC DFJDZTPFNSXNAX-UHFFFAOYSA-N 0.000 description 1
- RSIHJDGMBDPTIM-UHFFFAOYSA-N ethoxy(trimethyl)silane Chemical compound CCO[Si](C)(C)C RSIHJDGMBDPTIM-UHFFFAOYSA-N 0.000 description 1
- CWAFVXWRGIEBPL-UHFFFAOYSA-N ethoxysilane Chemical compound CCO[SiH3] CWAFVXWRGIEBPL-UHFFFAOYSA-N 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- WOLATMHLPFJRGC-UHFFFAOYSA-N furan-2,5-dione;styrene Chemical compound O=C1OC(=O)C=C1.C=CC1=CC=CC=C1 WOLATMHLPFJRGC-UHFFFAOYSA-N 0.000 description 1
- CZWLNMOIEMTDJY-UHFFFAOYSA-N hexyl(trimethoxy)silane Chemical compound CCCCCC[Si](OC)(OC)OC CZWLNMOIEMTDJY-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- POPACFLNWGUDSR-UHFFFAOYSA-N methoxy(trimethyl)silane Chemical compound CO[Si](C)(C)C POPACFLNWGUDSR-UHFFFAOYSA-N 0.000 description 1
- JIHUZDFFYVRXKP-UHFFFAOYSA-N methyl 2-trimethylsilylacetate Chemical compound COC(=O)C[Si](C)(C)C JIHUZDFFYVRXKP-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical group COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000005055 methyl trichlorosilane Substances 0.000 description 1
- JLUFWMXJHAVVNN-UHFFFAOYSA-N methyltrichlorosilane Chemical compound C[Si](Cl)(Cl)Cl JLUFWMXJHAVVNN-UHFFFAOYSA-N 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 1
- MQWFLKHKWJMCEN-UHFFFAOYSA-N n'-[3-[dimethoxy(methyl)silyl]propyl]ethane-1,2-diamine Chemical compound CO[Si](C)(OC)CCCNCCN MQWFLKHKWJMCEN-UHFFFAOYSA-N 0.000 description 1
- KBJFYLLAMSZSOG-UHFFFAOYSA-N n-(3-trimethoxysilylpropyl)aniline Chemical compound CO[Si](OC)(OC)CCCNC1=CC=CC=C1 KBJFYLLAMSZSOG-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- UQMGAWUIVYDWBP-UHFFFAOYSA-N silyl acetate Chemical class CC(=O)O[SiH3] UQMGAWUIVYDWBP-UHFFFAOYSA-N 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920006027 ternary co-polymer Polymers 0.000 description 1
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZGYICYBLPGRURT-UHFFFAOYSA-N tri(propan-2-yl)silicon Chemical compound CC(C)[Si](C(C)C)C(C)C ZGYICYBLPGRURT-UHFFFAOYSA-N 0.000 description 1
- PQSIXYSSKXAOFE-UHFFFAOYSA-N tri(propan-2-yl)silyl prop-2-enoate Chemical compound CC(C)[Si](C(C)C)(C(C)C)OC(=O)C=C PQSIXYSSKXAOFE-UHFFFAOYSA-N 0.000 description 1
- GQIUQDDJKHLHTB-UHFFFAOYSA-N trichloro(ethenyl)silane Chemical compound Cl[Si](Cl)(Cl)C=C GQIUQDDJKHLHTB-UHFFFAOYSA-N 0.000 description 1
- CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 description 1
- NBXZNTLFQLUFES-UHFFFAOYSA-N triethoxy(propyl)silane Chemical compound CCC[Si](OCC)(OCC)OCC NBXZNTLFQLUFES-UHFFFAOYSA-N 0.000 description 1
- HUZZQXYTKNNCOU-UHFFFAOYSA-N triethyl(methoxy)silane Chemical compound CC[Si](CC)(CC)OC HUZZQXYTKNNCOU-UHFFFAOYSA-N 0.000 description 1
- ZNOCGWVLWPVKAO-UHFFFAOYSA-N trimethoxy(phenyl)silane Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1 ZNOCGWVLWPVKAO-UHFFFAOYSA-N 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- HYWCXWRMUZYRPH-UHFFFAOYSA-N trimethyl(prop-2-enyl)silane Chemical compound C[Si](C)(C)CC=C HYWCXWRMUZYRPH-UHFFFAOYSA-N 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 229920006163 vinyl copolymer Polymers 0.000 description 1
- 239000005050 vinyl trichlorosilane Substances 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
本発明は、医療用輸液セットや医療用血液回路の医療用ジョイント管に好適に用いることのできる医療用塩化ビニル樹脂組成物に関する。更に詳しくは、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、差し込み易く、抜け難いことから、好適に用いることのできるものを得ることのできる医療用塩化ビニル樹脂組成物に関する。
The present invention relates to a medical polyvinyl chloride resin composition that can be suitably used for medical infusion sets and medical joint tubes of medical blood circuits. More specifically, as a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer, since it is easy to insert and difficult to pull out, it can be suitably used. The present invention relates to a medical vinyl chloride resin composition that can be obtained.
塩化ビニル樹脂に可塑剤が添加された塩化ビニル樹脂組成物は、可塑剤の量の多少により、広範囲な柔軟性の調整が可能であり、成形加工性(押出成形性、射出成型性)、接着性、耐熱性及び耐キンク性も良好であり、また低価格であることから、医療用器具、例えばカテーテル等の医療用チューブ、血液バッグ、薬液バッグ及びドレインバッグ等の医療用バック、医療用血液回路のジョイント部材、及び医療用容器などの材料として広く使用されている。 A vinyl chloride resin composition in which a plasticizer is added to a vinyl chloride resin can be adjusted in a wide range of flexibility depending on the amount of the plasticizer, molding processability (extrusion moldability, injection moldability), adhesion The medical device such as a medical tube such as a catheter, a blood bag, a medical solution bag and a drain bag, medical blood, etc. It is widely used as a material for circuit joint members and medical containers.
一般に、医療用器具に供される樹脂組成物には、溶出試験に合格することが求められる。また医療用輸液セットや医療用血液回路においては、チューブとジョイント管との差し込み易さ、及び抜け難さが重要である。最近、塩化ビニル樹脂組成物の一般的な可塑剤であるジ(2−エチルヘキシル)フタレート(DOP)は、昨今の環境問題により使用量が減少しており、医療用とでは代替可塑剤としてシクロヘキサンジカルボキシレート系可塑剤が検討されている。しかし、シクロヘキサンジカルボキシレート系可塑剤を可塑剤として含む塩化ビニル樹脂組成物からなる医療用輸液セットや医療用血液回路は、チューブとジョイント管との差し込み易さ、及び抜け難さが十分ではなかった(特許文献1、2)。
Generally, a resin composition used for a medical instrument is required to pass a dissolution test. Further, in medical infusion sets and medical blood circuits, it is important to easily insert and remove tubes and joint tubes. Recently, di (2-ethylhexyl) phthalate (DOP), which is a general plasticizer for vinyl chloride resin compositions, has been used in a reduced amount due to the recent environmental problems. Carboxylate plasticizers are being studied. However, medical infusion sets and medical blood circuits made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate plasticizer as a plasticizer are not sufficient for easy insertion and removal of tubes and joint tubes. (Patent Documents 1 and 2).
本発明は上記事情に鑑みてなされたものであり、その課題は、医療用輸液セットや医療用血液回路の医療用ジョイント管、特にシクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、差し込み易く、抜け難いことから、また医療用材料に要求される溶出性試験において問題のないことから、好適に用いることのできる医療用ジョイント管を得ることのできる医療用塩化ビニル樹脂組成物を提供することである。
This invention is made | formed in view of the said situation, The subject consists of a vinyl chloride resin composition containing the medical infusion set and the medical joint pipe | tube of a medical blood circuit, especially a cyclohexane dicarboxylate type plasticizer. As a medical joint tube for connecting a medical tube, it is easy to insert and difficult to remove, and since there is no problem in the elution test required for medical materials, it can be used preferably. It is providing the medical use vinyl chloride resin composition which can be obtained.
本発明者は、鋭意研究した結果、塩化ビニル樹脂の可塑剤として特定量のシクロヘキサンジカルボキシレート系可塑剤と特定量のエポキシ化植物油を用いることにより、上記課題を達成できることを見出した。 As a result of intensive studies, the present inventor has found that the above-mentioned problems can be achieved by using a specific amount of cyclohexanedicarboxylate plasticizer and a specific amount of epoxidized vegetable oil as a plasticizer for vinyl chloride resin.
すなわち、本発明の第一の発明は、
成分(a)塩化ビニル樹脂100質量部;
成分(b)シクロヘキサンジカルボキシレート系可塑剤1〜20質量部;
成分(c)エポキシ化植物油1〜9質量部;
を含有することを特徴とする医療用塩化ビニル樹脂組成物である。
That is, the first invention of the present invention is
Component (a) 100 parts by weight of vinyl chloride resin;
Component (b) 1-20 parts by mass of a cyclohexanedicarboxylate plasticizer;
Component (c) 1-9 parts by weight of epoxidized vegetable oil;
It is a medical vinyl chloride resin composition characterized by containing.
第二の発明は、上記成分(b)が、ジイソノニルシクロヘキサン−1,2−ジカルボキシレートであることを特徴とする第一の発明に記載の医療用塩化ビニル樹脂組成物である。 A second invention is the medical vinyl chloride resin composition according to the first invention, wherein the component (b) is diisononylcyclohexane-1,2-dicarboxylate.
第三の発明は、更に成分(d)シラン化合物を、上記成分(a)100質量部に対して0.1〜15質量部含有することを特徴とする第一の発明又は第二の発明に記載の医療用塩化ビニル樹脂組成物である。 The third invention further comprises 0.1 to 15 parts by mass of the component (d) silane compound with respect to 100 parts by mass of the component (a). The medical vinyl chloride resin composition described.
第四の発明は、医療用の輸液セット又は血液回路のジョイント管用であることを特徴とする第一〜三の発明の何れか1に記載の医療用塩化ビニル樹脂組成物である。 A fourth invention is the medical vinyl chloride resin composition according to any one of the first to third inventions, characterized in that it is used for medical infusion sets or blood circuit joint tubes.
第五の発明は、シクロヘキサンジカルボキシレート系可塑剤含有塩化ビニル樹脂組成物からなる医療用チューブの接続に用いるジョイント管用であることを特徴とする第一〜四の発明の何れか1に記載の医療用塩化ビニル樹脂組成物である。 5th invention is a joint pipe used for the connection of the medical tube which consists of a cyclohexane dicarboxylate type plasticizer containing vinyl chloride resin composition, It is any 1 of the invention of 1st-4th characterized by the above-mentioned. It is a medical vinyl chloride resin composition.
第六の発明は、第一〜五の発明の何れか1に記載の医療用塩化ビニル樹脂組成物からなることを特徴とする医療用の輸液セット又は血液回路のジョイント管である。 A sixth invention is a medical infusion set or a blood circuit joint tube comprising the medical vinyl chloride resin composition described in any one of the first to fifth inventions.
第七の発明は、シクロヘキサンジカルボキシレート系可塑剤含有塩化ビニル樹脂組成物からなる医療用チューブの接続への、第六の発明に記載のジョイント管の使用である。
A seventh invention is the use of the joint pipe according to the sixth invention to connection of a medical tube made of a cyclohexanedicarboxylate-based plasticizer-containing vinyl chloride resin composition.
本発明の医療用塩化ビニル樹脂組成物からなる医療用ジョイント管は、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、差し込み易く、抜け難いことから、また医療用材料に要求される溶出性試験において問題のないことから、好適に用いることができる。
The medical joint pipe made of the medical vinyl chloride resin composition of the present invention can be easily inserted as a medical joint pipe for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate plasticizer. It can be suitably used because it is difficult to come out and there is no problem in the dissolution test required for medical materials.
本発明の組成物を構成する各成分について、説明する。 Each component constituting the composition of the present invention will be described.
成分(a)「塩化ビニル樹脂」(必須成分)
本発明の成分(a)として用いる塩化ビニル樹脂は、−CH2−CHCl−で表される基を有する全ての重合体を指し、塩化ビニルの単独重合体;塩化ビニル・酢酸ビニル共重合体、塩化ビニル・(メタ)アクリル酸共重合体、塩化ビニル・(メタ)アクリル酸メチル共重合体、塩化ビニル・(メタ)アクリル酸エチル共重合体、塩化ビニル・マレイン酸エステル共重合体、塩化ビニル・エチレン共重合体、塩化ビニル・プロピレン共重合体、塩化ビニル・スチレン共重合体、塩化ビニル・イソブチレン共重合体、塩化ビニル・塩化ビニリデン共重合体、塩化ビニル・スチレン・無水マレイン酸三元共重合体、塩化ビニル・スチレン・アクリロニトリル三元共重合体、塩化ビニル・ブタジエン共重合体、塩化ビニル・イソプレン共重合体、塩化ビニル・塩素化プロピレン共重合体、塩化ビニル・塩化ビニリデン・酢酸ビニル三元共重合体、塩化ビニル・アクリロニトリル共重合体、塩化ビニル・各種ビニルエーテル共重合体等の塩化ビニルと塩化ビニルと共重合可能な他のモノマーとの共重合体;後塩素化ビニル共重合体等の塩化ビニル単独重合体や塩化ビニル系共重合体を改質したもの;更には塩素化ポリエチレン等の構造上塩化ビニル樹脂と類似の塩素化ポリオレフィンを包含する。
Component (a) "Vinyl chloride resin" (essential component)
The vinyl chloride resin used as component (a) of the present invention refers to all polymers having a group represented by —CH 2 —CHCl—, a vinyl chloride homopolymer; a vinyl chloride / vinyl acetate copolymer, Vinyl chloride / (meth) acrylic acid copolymer, vinyl chloride / methyl (meth) acrylate copolymer, vinyl chloride / (meth) ethyl acrylate copolymer, vinyl chloride / maleic acid ester copolymer, vinyl chloride・ Ethylene copolymer, vinyl chloride / propylene copolymer, vinyl chloride / styrene copolymer, vinyl chloride / isobutylene copolymer, vinyl chloride / vinylidene chloride copolymer, vinyl chloride / styrene / maleic anhydride ternary copolymer Polymer, vinyl chloride / styrene / acrylonitrile terpolymer, vinyl chloride / butadiene copolymer, vinyl chloride / isoprene copolymer, Copolymerized with vinyl chloride and vinyl chloride, such as vinyl chloride / chlorinated propylene copolymer, vinyl chloride / vinylidene chloride / vinyl acetate terpolymer, vinyl chloride / acrylonitrile copolymer, vinyl chloride / various vinyl ether copolymers, etc. Copolymers with other possible monomers; Post-chlorinated vinyl copolymers and other vinyl chloride homopolymers and modified vinyl chloride copolymers; and structurally vinyl chloride resins such as chlorinated polyethylene And similar chlorinated polyolefins.
本発明の成分(a)として用いる塩化ビニル樹脂の数平均重合度は、300以上7000以下が好ましく、400以上2000以下がより好ましい。 The number average polymerization degree of the vinyl chloride resin used as the component (a) of the present invention is preferably from 300 to 7,000, more preferably from 400 to 2,000.
本発明の成分(a)としては、これらの塩化ビニル樹脂の1種又は2種以上の混合物を用いることができる。 As the component (a) of the present invention, one or a mixture of two or more of these vinyl chloride resins can be used.
成分(b)「シクロヘキサンジカルボキシレート系可塑剤」(必須成分)
本発明の成分(b)として用いるシクロヘキサンジカルボキシレート系可塑剤は、シクロヘキサン−1,2−ジカルボン酸と、直鎖状又は分岐鎖状の炭素数1〜20の一価アルコールとのエステル化合物である。
Component (b) “cyclohexane dicarboxylate plasticizer” (essential component)
The cyclohexane dicarboxylate plasticizer used as component (b) of the present invention is an ester compound of cyclohexane-1,2-dicarboxylic acid and a linear or branched monohydric alcohol having 1 to 20 carbon atoms. is there.
上記成分(b)としては、例えば、ジメチルシクロヘキサン−1,2−ジカルボキシレート、ジエチルシクロヘキサン−1,2−ジカルボキシレート、ジn−ブチルシクロヘキサン−1,2−ジカルボキシレート、ジ−2−エチルヘキシルシクロヘキサン−1,2−ジカルボキシレート、ジイソノニルシクロヘキサン−1,2−ジカルボキシレート、ジイソデシルシクロヘキサン−1,2−ジカルボキシレートなどをあげることができる。成分(b)としては、これらの1種又は2種以上の混合物を用いることができる。これらの中で、ジイソノニルシクロヘキサン−1,2−ジカルボキシレートが好ましい。シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として差し込み易く、抜け難く、医療用材料に要求される溶出性試験において問題のないものを得ることができる。 Examples of the component (b) include dimethylcyclohexane-1,2-dicarboxylate, diethylcyclohexane-1,2-dicarboxylate, di-n-butylcyclohexane-1,2-dicarboxylate, di-2- Examples thereof include ethylhexylcyclohexane-1,2-dicarboxylate, diisononylcyclohexane-1,2-dicarboxylate, and diisodecylcyclohexane-1,2-dicarboxylate. As the component (b), one or a mixture of two or more of these can be used. Of these, diisononylcyclohexane-1,2-dicarboxylate is preferred. Easy to insert as a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer, difficult to remove, and has no problems in the dissolution test required for medical materials Can be obtained.
上記成分(b)の市販品としては、BASF社製の「Hexamoll(登録商標)DINCH(商品名)」があげられる。 Examples of commercially available components (b) include “Hexamol (registered trademark) DINCH (trade name)” manufactured by BASF.
上記成分(b)の配合量は、上記成分(a)100質量部に対して、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として差し込み易く、抜け難く、医療用材料に要求される溶出性試験において問題のないものを得るために、1質量部以上である。好ましくは3質量部以上である。また医療用輸液セット等のジョイント管として求められる剛性を保持し、差し込まれたチューブを抜け難くする観点から20質量部以下である。好ましくは18質量部以下である。 The compounding amount of the component (b) is a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer to 100 parts by mass of the component (a). In order to obtain a material that is easy to insert, difficult to remove, and has no problem in the dissolution test required for medical materials, the content is 1 part by mass or more. Preferably it is 3 parts by mass or more. Moreover, it is 20 mass parts or less from a viewpoint of hold | maintaining the rigidity calculated | required as joint pipes, such as a medical infusion set, and making it difficult to remove | insert the inserted tube. The amount is preferably 18 parts by mass or less.
成分(c)「エポキシ化植物油」(必須成分)
本発明の成分(c)として用いるエポキシ化植物油は、天然に産する植物油を過酸化水素や過酢酸等の有機過酸によってエポキシ化する公知の方法により製造されるものであり、エポキシ化大豆油、エポキシ化アマニ油などがあげられる。成分(c)としては、これらの1種又は2種以上の混合物を用いることができる。
Ingredient (c) "epoxidized vegetable oil" (essential ingredient)
The epoxidized vegetable oil used as component (c) of the present invention is produced by a known method of epoxidizing a naturally occurring vegetable oil with an organic peracid such as hydrogen peroxide or peracetic acid. And epoxidized linseed oil. As the component (c), one or a mixture of two or more of these can be used.
上記エポキシ化大豆油としては、例えば、粘度が100〜800mPa・s(25℃)ものがあげられる。またオキシラン酸素比率が6.0%〜7.0%のものが好ましい。シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、差し込み易く、抜け難いものが得られる。特にオキシラン酸素比率が6.0%〜6.6%であり、かつヨウ素価が6以下の場合にシクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、その差し込み易さ、及び抜け難さに驚くべき効果がある。 Examples of the epoxidized soybean oil include those having a viscosity of 100 to 800 mPa · s (25 ° C.). Further, those having an oxirane oxygen ratio of 6.0% to 7.0% are preferred. As a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer, an easy-to-insert and difficult-to-remove product is obtained. Particularly for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer when the oxirane oxygen ratio is 6.0% to 6.6% and the iodine value is 6 or less. As a medical joint tube, it has a surprising effect on its ease of insertion and difficulty in removal.
なお上記粘度は、JIS K 7117−1:1999に従い、B型粘度計を使用して測定した値である。またオキシラン酸素比率は、日本油学会の基準油脂分析試験法(2013年版)に基づき、試料を氷酢酸に溶解させ、クリスタルバイオレットを指示薬として、臭化水素酸の氷酢酸溶液で滴定を行い、測定した値である。ヨウ素価は、JIS
K 0070:1992に従い測定した値である。
The viscosity is a value measured using a B-type viscometer according to JIS K 7117-1: 1999. The oxirane oxygen ratio was measured by dissolving the sample in glacial acetic acid and titrating with glacial acetic acid solution of hydrobromic acid using crystal violet as an indicator based on the standard method for analysis of oils and fats (2013 version) of the Japan Oil Society. It is the value. Iodine value is JIS
K 0070: Measured according to 1992.
上記成分(c)の市販品としては、株式会社ADEKAのエポキシ化大豆油「O−130P(商品名)」、エポキシ化アマニ油「O−180A(商品名)」などをあげることができる。 Examples of commercially available components (c) include epoxidized soybean oil “O-130P (trade name)” and epoxidized linseed oil “O-180A (trade name)” manufactured by ADEKA Corporation.
上記成分(c)の配合量は、上記成分(a)100質量部に対して、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として差し込み易く、抜け難く、医療用材料に要求される溶出性試験において問題のないものを得るために、1質量部以上である。好ましくは2質量部以上である。またシクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として差し込み易く、抜け難いものを得るために、9質量部以下である。好ましくは8質量部以下である。 The compounding amount of the component (c) is a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer to 100 parts by mass of the component (a). In order to obtain a material that is easy to insert, difficult to remove, and has no problem in the dissolution test required for medical materials, the content is 1 part by mass or more. Preferably it is 2 parts by mass or more. Further, the amount is 9 parts by mass or less in order to obtain a medical joint tube that is easy to insert as a medical tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer and is difficult to be removed. Preferably it is 8 mass parts or less.
成分(d)「シラン化合物」(任意成分)
本発明の任意成分として使用するシラン化合物は、アルコキシシラン化合物、クロロシラン化合物、アセトキシシラン化合物及びオルガノシラン化合物からなる群から選択される1種以上のシラン化合物である。
Component (d) “Silane compound” (optional component)
The silane compound used as an optional component of the present invention is one or more silane compounds selected from the group consisting of alkoxysilane compounds, chlorosilane compounds, acetoxysilane compounds, and organosilane compounds.
上記成分(d)を、上記成分(a)100重量部に対して、0.1〜15重量部用いることにより、0.1〜15重量部用いることにより、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、その差し込み易さ、及び抜け難さが更に向上したものを得ることができる。より好ましくは1〜15質量部である。 By using 0.1 to 15 parts by weight of the component (d) with respect to 100 parts by weight of the component (a), 0.1 to 15 parts by weight are used, thereby including a cyclohexanedicarboxylate-based plasticizer. As a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition, it is possible to obtain a tube with further improved ease of insertion and removal. More preferably, it is 1-15 mass parts.
上記アルコキシシラン化合物としては、例えば、トリメチルメトキシシラン、トリメチルエトキシシラン、トリエチルメトキシシラン、トリエチルエトキシシランなどのモノアルコキシシラン化合物;ジメチルジメトキシシラン、ジエチルジメトキシシラン、ジメチルジエトキシシラン、ジフェニルジメトキシシラン、ジフェニルジエトキシシラン、メチルアミノエトキシプロピルジアルコキシシラン、N−(βアミノエチル)−γ−アミノプロピルメチルジメトキシシラン、γ−グリシドキシプロピルメチルジメトキシシラン、γ−メタクリロキシプロピルメチルジメトキシシランなどのジアルコキシシラン化合物;メチルトリメトキシシラン、メチルトリエトキシシラン、ヘキシルトリメトキシシラン、フェニルトリメトキシシラン、フェニルトリエトキシシラン、ビニルトリメトキシシラン、ビニルトリエトキシシラン、γ−クロロプロピルトリメトキシシラン、γ−アミノプロピルトリエトキシシラン、N−(β−アミノエチル)−γ−アミノプロピルトリメトキシシラン、N−(フェニル)−γ−アミノプロピルトリメトキシシラン、γ−グリシドキシプロピルトリメトキシシラン、3−メタクリロキシプロピルトリメトキシシラン、3−メタクリロキシプロピルトリエトキシシラン、γ−メルカプトプロピルトリメトキシシラン、γ−(ポリエチレンアミノ)プロピルトリメトキシシラン、γ−ウレイドプロピルトリエトキシシラン、ヘプタデカフルオロデシルトリメトキシシラン、トリデカフルオロオクチルトリメトキシシラン、ビニルトリス(β−メトキシエトキシ)シラン、β−(3,4−エポキシシクロヘキシル)エチルトリメトキシシランなどのトリアルコキシシラン化合物;テトラメトキシシラン、テトラエトキシシランなどのテトラアルコキシシラン化合物などがあげられる。 Examples of the alkoxysilane compound include monoalkoxysilane compounds such as trimethylmethoxysilane, trimethylethoxysilane, triethylmethoxysilane, and triethylethoxysilane; dimethyldimethoxysilane, diethyldimethoxysilane, dimethyldiethoxysilane, diphenyldimethoxysilane, diphenyldi Dialkoxysilanes such as ethoxysilane, methylaminoethoxypropyl dialkoxysilane, N- (βaminoethyl) -γ-aminopropylmethyldimethoxysilane, γ-glycidoxypropylmethyldimethoxysilane, γ-methacryloxypropylmethyldimethoxysilane Compound: methyltrimethoxysilane, methyltriethoxysilane, hexyltrimethoxysilane, phenyltrimethoxysilane, phenoxy Rutriethoxysilane, vinyltrimethoxysilane, vinyltriethoxysilane, γ-chloropropyltrimethoxysilane, γ-aminopropyltriethoxysilane, N- (β-aminoethyl) -γ-aminopropyltrimethoxysilane, N- ( Phenyl) -γ-aminopropyltrimethoxysilane, γ-glycidoxypropyltrimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropyltriethoxysilane, γ-mercaptopropyltrimethoxysilane, γ- ( Polyethyleneamino) propyltrimethoxysilane, γ-ureidopropyltriethoxysilane, heptadecafluorodecyltrimethoxysilane, tridecafluorooctyltrimethoxysilane, vinyltris (β-methoxyethoxy) silane Trialkoxysilane compounds such as beta-(3,4-epoxycyclohexyl) ethyltrimethoxysilane; tetramethoxysilane, tetra-alkoxysilane compounds such as tetraethoxysilane and the like.
上記アセトキシシラン化合物としては、例えば、ビニルトリアセトキシシランなどがあげられる。 Examples of the acetoxysilane compound include vinyltriacetoxysilane.
上記クロロシラン化合物としては、例えば、トリメチルクロロシラン、ジメチルジクロロシラン、メチルトリクロロシラン、ビニルトリクロロシラン、γ−クロロプロピルメチルジクロロシランなどがあげられる。 Examples of the chlorosilane compound include trimethylchlorosilane, dimethyldichlorosilane, methyltrichlorosilane, vinyltrichlorosilane, and γ-chloropropylmethyldichlorosilane.
上記オルガノシラン化合物とは、上記のアルコキシシラン化合物、アセトキシシラン化合物、及びクロロシラン化合物以外の、ケイ素原子に、アルキル基、ビニル基、(メタ)アクリル基、アリル基、酢酸メチル基などの基が直接結合しているシラン化合物を示すものであり、例えば、トリイソプロピルシラン、トリイソプロピルシリルアクリレート、アリルトリメチルシラン、トリメチルシリル酢酸メチルなどがあげられる。 The organosilane compound is a group other than the alkoxysilane compound, the acetoxysilane compound, and the chlorosilane compound, and a group such as an alkyl group, a vinyl group, a (meth) acryl group, an allyl group, or a methyl acetate group directly on the silicon atom. This indicates a bonded silane compound, and examples thereof include triisopropylsilane, triisopropylsilyl acrylate, allyltrimethylsilane, and methyl trimethylsilylacetate.
これらのシラン化合物の中でも、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として差し込み易く、抜け難いものを得るために、モノアルコキシシラン化合物、ジアルコキシシラン化合物、トリアルコキシシラン化合物及びテトラアルコキシシラン化合物からなる群から選択される1種以上のアルコキシシラン化合物が好ましく、トリアルコキシシラン化合物、テトラアルコキシシラン化合物がより好ましく、3−メタクリロキシプロピルトリエトキシシランが更に好ましい。 Among these silane compounds, monoalkoxysilane is used for obtaining a medical joint tube that is easy to insert as a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer and is difficult to be removed. One or more alkoxysilane compounds selected from the group consisting of compounds, dialkoxysilane compounds, trialkoxysilane compounds and tetraalkoxysilane compounds are preferred, trialkoxysilane compounds and tetraalkoxysilane compounds are more preferred, and 3-methacryloxy More preferred is propyltriethoxysilane.
また、本発明においては、これらのシラン化合物を2種以上併用することも可能であり、特に限定されるものではない。 Moreover, in this invention, it is also possible to use 2 or more types of these silane compounds together, and it does not specifically limit.
また、本発明の医療用塩化ビニル樹脂組成物には、任意成分として、医療用途向け硬質塩化ビニル樹脂に通常用いられる安定剤を配合してもよい。上記安定剤としては、例えば、有機スズ化合物、バリウム−亜鉛系及びカルシウム−亜鉛系の安定剤があげられる。発明の効果の観点から、好ましい安定剤は、有機スズ化合物である。安定剤の配合量は、成分(a)100質量部に対して、0.1〜10質量部が好ましい。また、滑剤として例えばポリエチレンワックスを添加することができる。 Moreover, you may mix | blend the stabilizer normally used for the hard vinyl chloride resin for medical uses as an arbitrary component with the medical vinyl chloride resin composition of this invention. Examples of the stabilizer include organotin compounds, barium-zinc and calcium-zinc stabilizers. From the viewpoint of the effect of the invention, a preferred stabilizer is an organotin compound. As for the compounding quantity of a stabilizer, 0.1-10 mass parts is preferable with respect to 100 mass parts of component (a). Further, for example, polyethylene wax can be added as a lubricant.
本発明の医療用塩化ビニル樹脂組成物は、成分(a)塩化ビニル樹脂、成分(b)シクロヘキサンジカルボキシレート系可塑剤、成分(c)エポキシ化植物油及び、所望に応じて用いる任意成分を、単軸押出機、二軸押出機、ロール、ミキサー又は各種のニーダー等を使用して溶融混練することにより得ることができる。好ましくは二軸押出機を用い、樹脂温度150〜180℃で溶融混練することにより得ることができる。 The medical vinyl chloride resin composition of the present invention comprises component (a) vinyl chloride resin, component (b) cyclohexanedicarboxylate plasticizer, component (c) epoxidized vegetable oil, and optional components used as desired. It can be obtained by melt kneading using a single screw extruder, a twin screw extruder, a roll, a mixer or various kneaders. Preferably, it can be obtained by melt kneading at a resin temperature of 150 to 180 ° C. using a twin screw extruder.
本発明の医療用ジョイント管は、本発明の医療用塩化ビニル樹脂組成物を用いて射出成型又は押出成形することにより得られる。好ましくは射出成型することにより得られる。ジョイント管はコネクター、チューブアダプターとも呼ばれ、その形状は略円筒形やT字型であり、分岐コック機能をもつものもある。
The medical joint pipe of the present invention can be obtained by injection molding or extrusion molding using the medical vinyl chloride resin composition of the present invention. Preferably it is obtained by injection molding. The joint pipe is also called a connector or a tube adapter, and its shape is substantially cylindrical or T-shaped, and some have a branch cock function.
以下、本発明を実施例により説明するが、本発明はこれに限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention, this invention is not limited to this.
使用した原材料
成分(a)塩化ビニル樹脂
成分(a−1):
製造会社:株式会社カネカ
種類: ポリ塩化ビニル
平均重合度:700
Raw materials used Component (a) Vinyl chloride resin component (a-1):
Manufacturer: Kaneka Corporation Type: Polyvinyl chloride Average degree of polymerization: 700
成分(b)シクロヘキサンジカルボキシレート系可塑剤
成分(b−1):
製造会社: BASFジャパン株式会社
商品名:HexamollR DINCH
種類:ジイソノニルシクロヘキサン−1,2−ジカルボキシレート(DINCH)
Component (b) Cyclohexanedicarboxylate-based plasticizer component (b-1):
Manufacturer: BASF Japan Ltd. Product Name: Hexamol R DINCH
Type: Diisononylcyclohexane-1,2-dicarboxylate (DINCH)
成分(c)エポキシ化植物油
成分(c−1):エポキシ化大豆油
製造会社:株式会社ADEKA
商品名:O−130P
粘度:280mPa・s(25℃)
オキシラン酸素比率:6.7%
ヨウ素価:2
Component (c) Epoxidized vegetable oil component (c-1): Epoxidized soybean oil Manufacturer: ADEKA Corporation
Product name: O-130P
Viscosity: 280 mPa · s (25 ° C)
Oxirane oxygen ratio: 6.7%
Iodine number: 2
成分(c−2)エポキシ化大豆油
粘度:280mPa・s(25℃)
オキシラン酸素比率:6.3%
ヨウ素価:2
Component (c-2) Epoxidized soybean oil viscosity: 280 mPa · s (25 ° C.)
Oxirane oxygen ratio: 6.3%
Iodine number: 2
成分(c−3)エポキシ化アマニ油
製造会社:株式会社ADEKA
商品名:O−180A
粘度:650mPa・s(25℃)
オキシラン酸素比率:9.1%
ヨウ素価:5
Component (c-3) Epoxidized linseed oil manufacturing company: ADEKA Corporation
Product name: O-180A
Viscosity: 650 mPa · s (25 ° C)
Oxirane oxygen ratio: 9.1%
Iodine number: 5
成分(d)シラン化合物
成分(d−1): トリアルコキシシラン化合物
製造会社:東レダウコーニングシリコン株式会社
商品名: Z−6036
種類:3−メタクリロキシプロピルトリエトキシシラン
Component (d) Silane Compound Component (d-1): Trialkoxysilane Compound Manufacturing Company: Toray Dow Corning Silicon Co., Ltd. Product Name: Z-6036
Type: 3-methacryloxypropyltriethoxysilane
成分(d−2): トリアルコキシシラン化合物
製造会社:東レダウコーニングシリコン株式会社
商品名: Z−6519
種類:ビニルトリエトキシシラン
Component (d-2): Trialkoxysilane compound manufacturer: Toray Dow Corning Silicon Co., Ltd. Product name: Z-6519
Type: Vinyltriethoxysilane
成分(d−3): テトラアルコキシシラン化合物
製造会社:東レダウコーニングシリコン株式会社
商品名: Z−6697
種類:テトラエトキシシラン
Component (d-3): Tetraalkoxysilane compound manufacturer: Toray Dow Corning Silicon Co., Ltd. Product name: Z-6697
Type: Tetraethoxysilane
成分(e)その他の任意成分1(安定剤)
成分(e):ジオクチル錫ジメルカプト系安定剤
製造会社:株式会社ADEKA
商品名: アデカスタブ465
種類: ジオクチル錫ジメルカプト
Component (e) Other optional component 1 (stabilizer)
Ingredient (e): Dioctyltin dimercapto stabilizer Manufacturing company: ADEKA Corporation
Product Name: ADK STAB 465
Type: Dioctyltin dimercapto
成分(f)その他の任意成分2(滑材)
成分(f): ポリエチレンワックス系滑材
製造会社:三井化学株式会社
商品名: ハイワックス4202E
種類:ポリエチレンワックス
Component (f) Other optional component 2 (lubricant)
Ingredient (f): Polyethylene wax-based lubricant manufacturer: Mitsui Chemicals, Inc. Product name: High Wax 4202E
Type: Polyethylene wax
測定方法
1.医療用適性試験
「日本薬局方プラスチック製医薬品容器試験法」に準拠して以下の試験を行った。
Measuring method 1. Medical aptitude test The following test was conducted in accordance with the “Japanese Pharmacopoeia Plastic Drug Container Testing Method”.
1−1.試験液の調整
下記で得た塩化ビニル樹脂組成物をプレス成形して得た厚さ1mmの試験片15.00gを水で洗い、室温で乾燥した。この試験片を内容量500mlの三角フラスコに入れ、蒸留水300mlを加え、シリコンゴム栓にて密封したものを、高圧蒸気滅菌器を用いて121℃で60分間加熱した。減圧した後、試験片の入った三角フラスコを高圧蒸気滅菌器から取り出し、室温になるまで放置した。試験片を蒸留水とともに300ml容のメスフラスコに移し、蒸留水を追加して正確に300mlとし、これを試験液とした。また、ブランク試験液として、試験片を含まない試験液を上記の方法にて調製した。試験液及びブランク試験液につき、下記試験(i)〜(iv)を行った。
1-1. Preparation of test solution 15.00 g of a 1 mm thick test piece obtained by press-molding the vinyl chloride resin composition obtained below was washed with water and dried at room temperature. This test piece was put into an Erlenmeyer flask having an internal volume of 500 ml, added with 300 ml of distilled water, sealed with a silicone rubber stopper, and heated at 121 ° C. for 60 minutes using a high-pressure steam sterilizer. After decompression, the Erlenmeyer flask containing the test piece was taken out from the autoclave and left to reach room temperature. The test piece was transferred to a 300 ml volumetric flask together with distilled water, and distilled water was added to make exactly 300 ml, which was used as a test solution. Moreover, the test liquid which does not contain a test piece as a blank test liquid was prepared by said method. The following tests (i) to (iv) were performed on the test solution and the blank test solution.
(i)pH試験
METTLER TOLEDO社製のpH計「Seven Easy AG8603(商品名)」を使用して測定を行った。pH標準液で校正を行った後、試験液20mlに対し、蒸留水1000ml中に塩化カリウム1.0gが含まれる濃度の塩化カリウム水溶液1mlを加え、30秒間攪拌した後のpHを測定した。同様にしてブランク試験液のpHを測定した。試験液のpHとブランク試験液のpHとの差の絶対値をΔpHとして算出した。
(I) pH test Measurement was performed using a pH meter “Seven Easy AG8603 (trade name)” manufactured by METTER TOLEDO. After calibration with a pH standard solution, 1 ml of a potassium chloride aqueous solution having a concentration of 1.0 g of potassium chloride in 1000 ml of distilled water was added to 20 ml of the test solution, and the pH after stirring for 30 seconds was measured. Similarly, the pH of the blank test solution was measured. The absolute value of the difference between the pH of the test solution and the pH of the blank test solution was calculated as ΔpH.
(ii)過マンガン酸カリウム還元性物質試験
試験液を10ml採取し、100mlの三角フラスコに入れ、0.01N過マンガン酸カリウム(KMnO4)水溶液を20ml、希硫酸(和光純薬工業株式会社製の精密分析用濃硫酸(容量分析法による濃度96%)5.7mlを蒸留水10mlに加え、冷却後、更に蒸留水を加えて100mlとしたもの。)1mlを加え、3分間煮沸した後、室温まで冷却した。ヨウ化カリウム0.1gを加えて8分間放置後、0.01Nのチオ硫酸ナトリウム水溶液を15ml滴下した。10分放置後、指示薬としてデンプン試液を加えて攪拌し、0.01Nのチオ硫酸ナトリウム水溶液にて滴定し、溶液が透明になる終点を測定した。同様にブランク試験液についての測定を行った。過マンガン酸カリウム消費量は以下の式にて算出した。ΔKMnO4が大きいほど、過マンガン酸カリウム還元性物質(主に有機物)の溶出量が多いことを意味する。
KMnO4消費量(ΔKMnO4)=(ブランク試験液のKMnO4消費量)−(試験液のKMnO4消費量)
(Ii) 10 ml of a potassium permanganate reducing substance test test solution is collected, put into a 100 ml Erlenmeyer flask, 20 ml of 0.01N potassium permanganate (KMnO 4 ) aqueous solution, diluted sulfuric acid (manufactured by Wako Pure Chemical Industries, Ltd.) After adding 5.7 ml of concentrated sulfuric acid for precision analysis (concentration 96% by volumetric analysis) to 10 ml of distilled water, cooling, and adding distilled water to 100 ml.) After adding 1 ml and boiling for 3 minutes, Cooled to room temperature. After adding 0.1 g of potassium iodide and allowing to stand for 8 minutes, 15 ml of 0.01 N sodium thiosulfate aqueous solution was added dropwise. After standing for 10 minutes, a starch test solution was added as an indicator and stirred, and titrated with 0.01N aqueous sodium thiosulfate solution to measure the end point at which the solution became transparent. Similarly, measurement was performed on the blank test solution. The potassium permanganate consumption was calculated by the following formula. It means that the larger the ΔKMnO 4 , the greater the amount of potassium permanganate reducing substance (mainly organic matter) eluted.
KMnO 4 consumption (ΔKMnO 4 ) = (KMnO 4 consumption of blank test liquid) − (KMnO 4 consumption of test liquid)
(iii)蒸発残留物試験
試験液20mlを水浴上で蒸発凝固し、残留物を105℃で1時間乾燥し、その質量(mg)を量った。
(Iii) Evaporation residue test 20 ml of the test solution was evaporated and solidified on a water bath, the residue was dried at 105 ° C. for 1 hour, and its mass (mg) was measured.
(iv)紫外線吸収スペクトル試験
株式会社日立製作所製の紫外可視分光光度計「U−3010(商品名)」を使用して測定した。液厚10mmの石英セルに上記で調製したブランク試験液をとり、光度計の補正を行った後、上記で調製した試験液について同様に石英セルにとり、波長220〜350nmにおける吸光度の最大値を測定した。
(Iv) Ultraviolet absorption spectrum test The ultraviolet absorption spectrophotometer "U-3010 (trade name)" manufactured by Hitachi, Ltd. was used. Take the blank test solution prepared above in a quartz cell with a thickness of 10 mm and correct the photometer, then put the test solution prepared above in the same manner in the quartz cell and measure the maximum absorbance at a wavelength of 220 to 350 nm. did.
2.差し込み易さ試験
(1)下記で得た塩化ビニル樹脂組成物を用い、内径6mm、肉厚2mm(外径10mm)、長さ50mmの略円筒形のジョイント管を、射出成型機を使用して作成した。
(2)次に、塩化ビニル樹脂組成物(平均重合度1300のポリ塩化ビニル100質量部、ジイソノニルシクロヘキサン−1,2−ジカルボキシレート50質量部、及びカルシウム−亜鉛系の安定剤1質量部とを溶融混練して得たもの。)製の外径6mm、肉厚1mm、長さ1mのチューブを1本用意し、上記で得たジョイント管のジョイント部に、10mm差し込んで接続する際の差し込み易さを、試験者10名中の、差し込み易いと答えた人数の割合で評価した。
◎:非常に差し込み易い 10人/10人中
○:差し込み易い 5〜7人/10人中
△:やや差し込み難いい 2〜4人/10人中
×:差し込み難い 0人/10人中
2. Ease of insertion test (1) Using a vinyl chloride resin composition obtained below, an approximately cylindrical joint pipe having an inner diameter of 6 mm, a wall thickness of 2 mm (outer diameter of 10 mm), and a length of 50 mm was obtained using an injection molding machine. Created.
(2) Next, a vinyl chloride resin composition (100 parts by mass of polyvinyl chloride having an average degree of polymerization of 1300, 50 parts by mass of diisononylcyclohexane-1,2-dicarboxylate, and 1 part by mass of a calcium-zinc stabilizer) Prepared by melting and kneading.) One tube with an outer diameter of 6 mm, a wall thickness of 1 mm, and a length of 1 m was prepared, and 10 mm was inserted into the joint part of the joint pipe obtained above and inserted. Ease was evaluated by the ratio of the number of the 10 testers who answered that it was easy to insert.
◎: Very easy to insert 10 out of 10 people ○: Easy to insert 5 out of 7 people out of 10 people △: Slightly difficult to insert 2 out of 4 people out of 10 people ×: Difficult to insert out of 0 out of 10 people
3.抜け難さ試験
(1)下記で得た塩化ビニル樹脂組成物を用い、内径6mm、肉厚2mm(外径10mm)、長さ50mmの略円筒形のジョイント管を、射出成型機を使用して作成した。
(2)次に、塩化ビニル樹脂組成物(平均重合度1300のポリ塩化ビニル100質量部、ジイソノニルシクロヘキサン−1,2−ジカルボキシレート50質量部、及びカルシウム−亜鉛系の安定剤1質量部とを溶融混練して得たもの。)製の外径6mm、肉厚1mm、長さ1mのチューブを1本用意し、上記で得たジョイント管のジョイント部に、10mm差し込んで接続した後にJIS
K 7100:1999に準拠して温度80±2℃、湿度70±5%に調整した恒温恒湿槽「株式会社カトー製のSE−47CIA(商品名)」にチューブを接続したジョイント管を入れ、72時間放置し、さらに、恒温恒湿槽(温度23±2℃、湿度50±5%)に24時間放置した後、チューブをジョイント管から引き抜く際の抜け難さを、試験者10名中の、抜け難いと答えた人数の割合で評価した。
◎:非常に抜け難い 10人/10人中
○:抜け難い 5〜7人/10人中
△:やや抜け易い 2〜4人/10人中
×:抜け易い 0人/10人中
3. Detachability test (1) Using a vinyl chloride resin composition obtained below, an approximately cylindrical joint pipe having an inner diameter of 6 mm, a wall thickness of 2 mm (outer diameter of 10 mm), and a length of 50 mm was obtained using an injection molding machine. Created.
(2) Next, a vinyl chloride resin composition (100 parts by mass of polyvinyl chloride having an average degree of polymerization of 1300, 50 parts by mass of diisononylcyclohexane-1,2-dicarboxylate, and 1 part by mass of a calcium-zinc stabilizer) Obtained by melt kneading.) Prepare one tube of outer diameter 6mm, wall thickness 1mm, length 1m, and insert it 10mm into the joint part of the joint pipe obtained above, then connect it to JIS
K 7100: In accordance with 1999, put a joint pipe with a tube connected to a constant temperature and humidity chamber “SE-47CIA (trade name) manufactured by Kato Corporation” adjusted to a temperature of 80 ± 2 ° C. and a humidity of 70 ± 5%, It was allowed to stand for 72 hours, and after being left in a constant temperature and humidity chamber (temperature 23 ± 2 ° C., humidity 50 ± 5%) for 24 hours, Evaluation was based on the percentage of people who answered that it was difficult to escape.
◎: Very difficult to remove 10 out of 10 people ○: Difficult to remove 5 out of 7/10 people △: Slightly out of 2-4 people out of 10 people ×: Easy out of 0 out of 10 people
実施例1〜15、比較例1〜6
表1〜3の何れか1に示す量(質量部)の成分を、二軸押出機を用いて150〜180℃で溶融混練して塩化ビニル樹脂組成物を製造した。上記の試験1〜3を行った。結果を表1〜3の何れか1に示す。
Examples 1-15, Comparative Examples 1-6
A vinyl chloride resin composition was produced by melt-kneading the components (parts by mass) shown in any one of Tables 1 to 3 at 150 to 180 ° C. using a twin screw extruder. The above tests 1 to 3 were performed. The results are shown in any one of Tables 1-3.
表1〜3の何れか1に示すように、本発明の組成物は、シクロヘキサンジカルボキシレート系可塑剤を含む塩化ビニル樹脂組成物からなる医療用チューブを接続するための医療用ジョイント管として、差し込み易く、抜け難く、医療用材料に要求される溶出性試験において問題はない。一方、成分(b)の配合量が規定よりも少ない比較例1は試験2と3に劣る。成分(b)の配合量が規定よりも多い比較例2は試験3に劣る。成分(c)の配合量が規定よりも少ない比較例3は試験2と3に劣る。成分(c)の配合量が規定よりも多い比較例4は試験3に劣る。成分(c)を使用していない比較例5、6は試験2と3に劣る。
As shown in any one of Tables 1-3, the composition of the present invention is a medical joint tube for connecting a medical tube made of a vinyl chloride resin composition containing a cyclohexanedicarboxylate-based plasticizer. It is easy to insert and difficult to remove, and there is no problem in the dissolution test required for medical materials. On the other hand, Comparative Example 1 in which the blending amount of component (b) is less than specified is inferior to Tests 2 and 3. Comparative Example 2 in which the blending amount of component (b) is larger than specified is inferior to Test 3. Comparative Example 3 in which the amount of component (c) is less than specified is inferior to Tests 2 and 3. Comparative Example 4 in which the blending amount of component (c) is larger than specified is inferior to Test 3. The comparative examples 5 and 6 which do not use the component (c) are inferior to the tests 2 and 3.
Claims (7)
成分(b)シクロヘキサンジカルボキシレート系可塑剤1〜20質量部;
成分(c)エポキシ化植物油1〜9質量部;
を含有することを特徴とする医療用塩化ビニル樹脂組成物。
Component (a) 100 parts by weight of vinyl chloride resin;
Component (b) 1-20 parts by mass of a cyclohexanedicarboxylate plasticizer;
Component (c) 1-9 parts by weight of epoxidized vegetable oil;
A medical vinyl chloride resin composition comprising:
The medical vinyl chloride resin composition according to claim 1, wherein the component (b) is diisononylcyclohexane-1,2-dicarboxylate.
Furthermore, 0.1-15 mass parts of component (d) silane compounds are contained with respect to 100 mass parts of said component (a), The medical vinyl chloride resin composition of Claim 1 or 2 characterized by the above-mentioned.
The medical vinyl chloride resin composition according to any one of claims 1 to 3, which is used for a medical infusion set or a joint pipe of a blood circuit.
The medical vinyl chloride resin composition according to any one of claims 1 to 4, wherein the medical vinyl chloride resin composition is used for a joint pipe used for connection of a medical tube made of a cyclohexanedicarboxylate-based plasticizer-containing vinyl chloride resin composition. object.
A medical infusion set or a blood circuit joint tube comprising the medical vinyl chloride resin composition according to any one of claims 1 to 5.
Use of the joint pipe according to claim 6 to connection of a medical tube made of a cyclohexanedicarboxylate plasticizer-containing vinyl chloride resin composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013231033A JP6219133B2 (en) | 2013-11-07 | 2013-11-07 | Medical vinyl chloride resin composition and medical device comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013231033A JP6219133B2 (en) | 2013-11-07 | 2013-11-07 | Medical vinyl chloride resin composition and medical device comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015089931A true JP2015089931A (en) | 2015-05-11 |
JP6219133B2 JP6219133B2 (en) | 2017-10-25 |
Family
ID=53193616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013231033A Active JP6219133B2 (en) | 2013-11-07 | 2013-11-07 | Medical vinyl chloride resin composition and medical device comprising the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6219133B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10398625B2 (en) | 2013-03-13 | 2019-09-03 | Fenwal, Inc. | Medical containers with terephthalate plasticizer for storing red blood cell products |
US11160728B2 (en) | 2014-02-20 | 2021-11-02 | Fresenius Kabi Deutschland Gmbh | Medical containers and system components with non-DEHP plasticizers for storing red blood cell products, plasma and platelets |
WO2022005130A1 (en) * | 2020-07-01 | 2022-01-06 | 한화솔루션 주식회사 | Plasticizer composition and vinylchloride resin composition comprising same |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56116467A (en) * | 1980-02-19 | 1981-09-12 | Sumitomo Bakelite Co | Polyvinyl chloride resin composition for medical tool |
JPS598744A (en) * | 1982-07-08 | 1984-01-18 | Sumitomo Bakelite Co Ltd | Vinyl chloride resin composition |
JPS61240959A (en) * | 1985-04-17 | 1986-10-27 | テルモ株式会社 | Medical utensil |
JPH0243245A (en) * | 1988-06-06 | 1990-02-13 | B F Goodrich Co:The | Rigid vinyl polymer article resistant to discoloration by gamma-ray |
JPH0270740A (en) * | 1988-09-06 | 1990-03-09 | Matsumura Sekiyu Kenkyusho:Kk | Radiation-resistant polyvinyl chloride composition |
JP2006061226A (en) * | 2004-08-25 | 2006-03-09 | Sumitomo Bakelite Co Ltd | Catheter having connector |
WO2008032583A1 (en) * | 2006-09-11 | 2008-03-20 | Kaneka Corporation | Resin composition for medical use, resin pellets and part for medical use |
JP2008195898A (en) * | 2007-02-15 | 2008-08-28 | Showa Kasei Kogyo Kk | Hard vinyl chloride-based resin composition for medical use and hard parts for medical use using the same |
WO2012169081A1 (en) * | 2011-06-09 | 2012-12-13 | リケンテクノス株式会社 | Vinyl chloride resin composition |
WO2013031683A1 (en) * | 2011-08-31 | 2013-03-07 | リケンテクノス株式会社 | Vinyl chloride resin composition |
JP2015516009A (en) * | 2012-05-03 | 2015-06-04 | ロケット フレールRoquette Freres | Plasticizer composition comprising a gelling accelerator based on an ester of 1,4: 3,6-dianhydrohexitol having a low molecular weight |
-
2013
- 2013-11-07 JP JP2013231033A patent/JP6219133B2/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56116467A (en) * | 1980-02-19 | 1981-09-12 | Sumitomo Bakelite Co | Polyvinyl chloride resin composition for medical tool |
JPS598744A (en) * | 1982-07-08 | 1984-01-18 | Sumitomo Bakelite Co Ltd | Vinyl chloride resin composition |
JPS61240959A (en) * | 1985-04-17 | 1986-10-27 | テルモ株式会社 | Medical utensil |
JPH0243245A (en) * | 1988-06-06 | 1990-02-13 | B F Goodrich Co:The | Rigid vinyl polymer article resistant to discoloration by gamma-ray |
JPH0270740A (en) * | 1988-09-06 | 1990-03-09 | Matsumura Sekiyu Kenkyusho:Kk | Radiation-resistant polyvinyl chloride composition |
JP2006061226A (en) * | 2004-08-25 | 2006-03-09 | Sumitomo Bakelite Co Ltd | Catheter having connector |
WO2008032583A1 (en) * | 2006-09-11 | 2008-03-20 | Kaneka Corporation | Resin composition for medical use, resin pellets and part for medical use |
JP2008195898A (en) * | 2007-02-15 | 2008-08-28 | Showa Kasei Kogyo Kk | Hard vinyl chloride-based resin composition for medical use and hard parts for medical use using the same |
WO2012169081A1 (en) * | 2011-06-09 | 2012-12-13 | リケンテクノス株式会社 | Vinyl chloride resin composition |
JP2012255104A (en) * | 2011-06-09 | 2012-12-27 | Riken Technos Corp | Vinyl chloride resin composition |
WO2013031683A1 (en) * | 2011-08-31 | 2013-03-07 | リケンテクノス株式会社 | Vinyl chloride resin composition |
JP2013064113A (en) * | 2011-08-31 | 2013-04-11 | Riken Technos Corp | Vinyl chloride resin composition |
JP2015516009A (en) * | 2012-05-03 | 2015-06-04 | ロケット フレールRoquette Freres | Plasticizer composition comprising a gelling accelerator based on an ester of 1,4: 3,6-dianhydrohexitol having a low molecular weight |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10398625B2 (en) | 2013-03-13 | 2019-09-03 | Fenwal, Inc. | Medical containers with terephthalate plasticizer for storing red blood cell products |
US11957639B2 (en) | 2013-03-13 | 2024-04-16 | Fenwal, Inc. | Medical containers with terephthalate plasticizer for storing red blood cell products |
US11160728B2 (en) | 2014-02-20 | 2021-11-02 | Fresenius Kabi Deutschland Gmbh | Medical containers and system components with non-DEHP plasticizers for storing red blood cell products, plasma and platelets |
US12064396B2 (en) | 2014-02-20 | 2024-08-20 | Fresenius Kabi Deutschland Gmbh | Medical containers and system components with non-DEHP plasticizers for storing red blood cell products, plasma and platelets |
WO2022005130A1 (en) * | 2020-07-01 | 2022-01-06 | 한화솔루션 주식회사 | Plasticizer composition and vinylchloride resin composition comprising same |
CN115843304A (en) * | 2020-07-01 | 2023-03-24 | 韩华思路信(株) | Plasticizer composition and vinyl chloride resin composition comprising same |
JP2023532940A (en) * | 2020-07-01 | 2023-08-01 | ハンワ ソリューションズ コーポレイション | Plasticizer composition and vinyl chloride resin composition containing the same |
JP7553614B2 (en) | 2020-07-01 | 2024-09-18 | ハンワ ソリューションズ コーポレイション | Plasticizer composition and vinyl chloride resin composition containing the same |
Also Published As
Publication number | Publication date |
---|---|
JP6219133B2 (en) | 2017-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6219130B2 (en) | Medical vinyl chloride resin composition and medical device comprising the same | |
JP6148565B2 (en) | Medical radiation sterilized vinyl chloride resin composition and medical device comprising the same | |
JP5374154B2 (en) | Medical resin composition, resin pellets and medical parts | |
JP6059911B2 (en) | Vinyl chloride resin composition | |
JP5291294B2 (en) | Rigid medical vinyl chloride resin composition and rigid medical parts using the same | |
JP6148566B2 (en) | Medical radiation sterilized vinyl chloride resin composition and medical device comprising the same | |
JP5261504B2 (en) | Alternative plasticizer systems for phthalate plasticizing compounds | |
JP6219133B2 (en) | Medical vinyl chloride resin composition and medical device comprising the same | |
JP5267571B2 (en) | Adhesive composition | |
JP2012255104A (en) | Vinyl chloride resin composition | |
US10262767B2 (en) | Plasticizer for color retention during heat aging | |
JP6178658B2 (en) | Medical radiation sterilized vinyl chloride resin composition and medical device comprising the same | |
WO2016133166A1 (en) | 2-cyanoacrylate adhesive composition | |
JP6148570B2 (en) | Medical radiation sterilized vinyl chloride resin composition and medical device comprising the same | |
JP2019041873A (en) | Endoscope adhesive and cured material thereof, and endoscope and manufacturing method thereof | |
JP2015028117A (en) | Medical radiation sterilization corresponding vinyl chloride resin composition, and medical instrument formed from the same | |
JP2016044296A (en) | Medical vinyl chloride-based resin composition and medical device containing the same | |
JP6568679B2 (en) | Vinyl chloride resin composition | |
WO2019102995A1 (en) | Method to improve visibility of contents, vinyl chloride-based resin composition, stabilizer, vinyl chloride-based resin molded body, medical material, and sterilization processing method | |
JP2019041874A (en) | Endoscope adhesive and cured material thereof, and endoscope and manufacturing method thereof | |
JP2005006777A (en) | Tube for medical use | |
JP2016147954A (en) | Medical vinyl chloride-based resin composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161003 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170714 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170720 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170926 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170927 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6219133 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |